CUPERTINO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage ...

Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) had its price objective lowered by HC Wainwright from $14.00 to $11.00 ...

Reviva Pharmaceuticals Holdings Inc’s profitability metrics reveal financial health. The company currently boasts a gross margin of 90.48%. The profit margin, also known as the revenue ratio or gross ...

Shares of NASDAQ RVPH opened at $1.91 on Friday. Reviva Pharmaceuticals has a twelve month low of $0.60 and a twelve month high of $4.83. The firm has a 50-day moving average of $1.71 and a two ...

On November 14 th, 2024, Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported third quarter 2024 financial and operational results and filed its Form 10-Q with the SEC. Reviva provided ...

In recent trading, Reviva Pharmaceuticals Holdings Inc (RVPH) stock price has shown some volatility, fluctuating -19.80% over the last ...

Vandana Singh Analyst Assessment On Reviva Pharmaceuticals' Positive Schizophrenia Trial Data - Sees More Than 200% Upside In Stock Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) shares are ...

H.C. Wainwright lowered the firm’s price target on Reviva Pharmaceuticals (RVPH) to $11 from $14 and keeps a Buy rating on the shares. Johnson ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insmed (INSM – Research Report) and Reviva ...

1 Day RVPH -4.71% DJIA 0.65% Russell 2K -1.03% Health Care/Life Sciences -0.52% ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.